HEPATO CELLULAR CARCINOMA (HCC)
Clinical trials for HEPATO CELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new HEPATO CELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for HEPATO CELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise in slowing advanced liver cancer
Disease control Recruiting nowThis study tests whether adding chemotherapy to a combination of two drugs (camrelizumab and apatinib) helps people with advanced liver cancer live longer without their disease getting worse. About 326 adults with liver cancer that cannot be removed by surgery will be randomly as…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE3 • Sponsor: Linhui Peng • Aim: Disease control
Last updated May 17, 2026 09:18 UTC
-
New hope for liver cancer patients: smart trial seeks better Second-Line therapies
Disease control Recruiting nowThis study tests several new drug combinations for people with advanced liver cancer whose first treatment stopped working. About 350 adults will join, and researchers will use scans, blood tests, and tumor samples to find which treatment works best for each person. The goal is t…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 17, 2026 09:16 UTC
-
Liver cancer trial aims to boost chemo effectiveness with blood pressure drug
Disease control Recruiting nowThis study tests whether adding a blood pressure drug (nicardipine) to standard chemo delivered directly to the liver (TACE) can improve outcomes for people with liver cancer. About 152 adults with a single untreated tumor will be randomly assigned to receive either TACE plus nic…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Poop pills may reboot liver cancer treatment
Disease control Recruiting nowThis study tests whether a fecal microbiota transplant (FMT) can help people with advanced liver cancer whose disease got worse on standard therapy. Participants will receive FMT along with the same cancer drugs they previously took. The goal is to see if this approach can restor…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
New blood test could revolutionize liver cancer detection
Diagnosis Recruiting nowThis study is testing a new blood test called delta-HLD to see how well it can detect liver cancer (hepatocellular carcinoma). Researchers will compare results from 200 people—some with liver cancer and some with liver cirrhosis but no cancer—to measure the test's accuracy. If su…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Sponsor: Epiliquid Holding, Inc • Aim: Diagnosis
Last updated May 07, 2026 18:39 UTC
-
Liver cancer patients may soon recover at home instead of hospital
Symptom relief Recruiting nowThis study tests whether people with liver cancer can recover at home after a procedure that delivers chemotherapy directly to the tumor, instead of staying in the hospital. About 206 adults with liver cancer will be randomly assigned to either home or hospital recovery. Research…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC